Literature DB >> 2722878

A block of transcription elongation by RNA polymerase II at synthetic sites in vitro.

E Bengal1, Y Aloni.   

Abstract

We have previously suggested that transcription elongation by RNA polymerase II can be blocked when the nascent RNA is folded into a stem-and-loop structure followed by polyuridines. As an approach to test this suggestion in vitro, several GC-rich deoxyoligonucleotides with dyad symmetries were chemically synthesized and inserted following the adenovirus 2 major late promoter. These constructs were transcribed in vitro using HeLa whole cell extract. The transcripts of the synthetic inserts can potentially form stem-and-loop structures with destabilization energy from 0 to -48 kcal followed by 3, 5, and 8 U residues. The results obtained show that transcription elongation is blocked by these synthetic inserts and that the extent of the elongation block is directly correlated to the stabilities of the potential stem-and-loop structure and the proceeding number of U residues. Three levels of elongation blocks were observed: a brief pause of the polymerase occurs when the RNA could be folded into a secondary structure or when there were 5-6 T residues on the sense DNA strand. An extended pause occurred when the number of T residues on the sense DNA strand was increased to 8. Transcription termination, with a partial release of the attenuated transcript occurred when a stable RNA secondary structure (delta G = -48 kcal) was followed by 8 U residues. The relevancy of these in vitro results to the in vivo mechanism of a transcription elongation block is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

2.  Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract.

Authors:  L London; R G Keene; R Landick
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes.

Authors:  R G Keene; A Mueller; R Landick; L London
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.

Authors:  M E Greenberg; M B Mathews
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  In vitro analysis of elongation and termination by mutant RNA polymerases with altered termination behavior.

Authors:  S A Shaaban; E V Bobkova; D M Chudzik; B D Hall
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Sequence requirements for transcriptional arrest in exon 1 of the murine adenosine deaminase gene.

Authors:  V Ramamurthy; M C Maa; M L Harless; D A Wright; R E Kellems
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

7.  The block to transcription elongation at the minute virus of mice attenuator is regulated by cellular elongation factors.

Authors:  A Krauskopf; E Bengal; Y Aloni
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

8.  Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro.

Authors:  M A Graeble; M J Churcher; A D Lowe; M J Gait; J Karn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Stability of Drosophila RNA polymerase II elongation complexes in vitro.

Authors:  D D Kephart; N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation-responsive region of human immunodeficiency virus type 1 in vitro.

Authors:  E Bengal; Y Aloni
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.